What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoir
- PMID: 17006818
- DOI: 10.1086/508759
What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus control measures are negative (and other advice to young epidemiologists): a review and an au revoir
Abstract
The incidence of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) infections continues to rise in National Nosocomial Infections Surveillance system hospitals, and these pathogens are reportedly causing more than 100,000 infections and many deaths each year in US healthcare facilities. This has led some to insist that control measures are now urgently needed, but several recent articles have suggested that isolation of patients does not work, is not needed, or is unsafe, or that a single cluster-randomized trial could be used to decide such matters. At least 101 studies have reported controlling MRSA infection and 38 have reported controlling VRE infection by means of active detection by surveillance culture and use of isolation for all colonized patients in healthcare settings where the pathogens are epidemic or endemic, in academic and nonacademic hospitals, and in acute care, intensive care, and long-term care settings. MRSA colonization and infection have been controlled to exceedingly low levels in multiple nations and in the state of Western Australia for decades by use of active detection and isolation. Studies suggesting problems with using such data to control MRSA colonization and infection have their own problems, which are discussed. Randomized trials are epidemiologic tools that can sometimes provide erroneous results, and they have not been considered necessary for studying isolation before it is used to control other important infections, such as tuberculosis, smallpox, and severe acute respiratory syndrome. No single epidemiologic study should be considered definitive. One should always weigh all available evidence. Infection with antibiotic-resistant pathogens such as MRSA and VRE is controllable to a low level by active detection and isolation of colonized and infected patients. Effective measures should be used to minimize the morbidity and mortality attributable to these largely preventable infections.
Comment in
-
Design and methodology of the Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR-ICU) trial.Infect Control Hosp Epidemiol. 2007 Feb;28(2):245-6; author reply 246-8. doi: 10.1086/510988. Infect Control Hosp Epidemiol. 2007. PMID: 17301944 No abstract available.
Similar articles
-
Impact of alcohol-based, waterless hand antiseptic on the incidence of infection and colonization with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.Infect Control Hosp Epidemiol. 2006 Oct;27(10):1018-24. doi: 10.1086/507916. Epub 2006 Aug 31. Infect Control Hosp Epidemiol. 2006. PMID: 17006807
-
[Hospital infection control measures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci].Nihon Rinsho. 2002 Nov;60(11):2144-9. Nihon Rinsho. 2002. PMID: 12440120 Review. Japanese.
-
Survey of long-term-care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci.Infect Control Hosp Epidemiol. 2005 Oct;26(10):811-5. doi: 10.1086/502498. Infect Control Hosp Epidemiol. 2005. PMID: 16276955
-
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: recognition and prevention in intensive care units.Crit Care Med. 2010 Aug;38(8 Suppl):S335-44. doi: 10.1097/CCM.0b013e3181e6ab12. Crit Care Med. 2010. PMID: 20647791 Review.
-
SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.Infect Control Hosp Epidemiol. 2003 May;24(5):362-86. doi: 10.1086/502213. Infect Control Hosp Epidemiol. 2003. PMID: 12785411 Review.
Cited by
-
Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis.Infect Control Hosp Epidemiol. 2010 Jun;31(6):598-606. doi: 10.1086/652524. Infect Control Hosp Epidemiol. 2010. PMID: 20402588 Free PMC article.
-
Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006).Can J Infect Dis Med Microbiol. 2008 May;19(3):243-9. doi: 10.1155/2008/714846. Can J Infect Dis Med Microbiol. 2008. PMID: 19412382 Free PMC article.
-
A comparison of infection control program resources, activities, and antibiotic resistant organism rates in Canadian acute care hospitals in 1999 and 2005: pre- and post-severe acute respiratory syndrome.Am J Infect Control. 2008 Dec;36(10):711-7. doi: 10.1016/j.ajic.2008.02.008. Epub 2008 Oct 3. Am J Infect Control. 2008. PMID: 18834747 Free PMC article.
-
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.Antimicrob Agents Chemother. 2008 Apr;52(4):1430-7. doi: 10.1128/AAC.01538-07. Epub 2008 Feb 19. Antimicrob Agents Chemother. 2008. PMID: 18285482 Free PMC article.
-
Adverse outcomes associated with Contact Precautions: a review of the literature.Am J Infect Control. 2009 Mar;37(2):85-93. doi: 10.1016/j.ajic.2008.04.257. Am J Infect Control. 2009. PMID: 19249637 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical